Palvella Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PVLA and other ETFs, options, and stocks.About PVLA
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. It develops a pipeline of treatments for rare genetic skin diseases using its patented QTORIN platform.
PVLA Key Statistics
Stock Snapshot
With a market cap of 1.67B, Palvella Therapeutics(PVLA) trades at $116.51. The stock has a price-to-earnings ratio of -27.95.
On 2026-06-16, Palvella Therapeutics(PVLA) shares started trading at $112.09, with intraday highs of — and lows of —.
Trading volume for Palvella Therapeutics(PVLA) stock has reached 0, versus its average volume of 328.04K.
The stock's 52-week range extends from a low of $20.20 to a high of $151.18.
The stock's 52-week range extends from a low of $20.20 to a high of $151.18.
Analyst ratings
100%
of 17 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.